Frequently Asked Questions
The market is segmented based on Global Respiratory Syncytial Virus (RSV) Diagnostic Market, By Product (Kits and Assays, Instruments, Others), Method (Molecular Diagnostics, Rapid Antigen Detection Test, Others), End User (Hospitals and Clinics, Clinical Laboratories, Others) – Industry Trends and Forecast to 2030.
.
The Global Rsv Diagnostic Market size was valued at USD 923.10 USD Million in 2022.
The Global Rsv Diagnostic Market is projected to grow at a CAGR of 10.91% during the forecast period of 2023 to 2030.
The major players operating in the market include , BIOMERIEUX , BD , Abbott , F. Hoffman La. Roche Ltd , Danaher , Thermo Fisher Scientific , Luminex Corporation , BioCartis Hologic , Fast Track Diagnostics Luxembourg S.à r.l. , Beckman Coulter , Ortho,Clinical Diagnostics , Bio,Rad Laboratories , DiaSorin S.p.A. ,.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
